Target intelligence / Profile preview

Colonic wall and myenteric plexus components

Molecular classification
Other
01

Overview

The colonic wall and myenteric plexus (Auerbach's plexus) constitute the primary structural and neural framework responsible for gastrointestinal motility and homeostasis. The myenteric plexus is a collection of unmyelinated fibers and postganglionic autonomic cell bodies situated between the circular and longitudinal muscle layers of the muscularis externa (StatPearls, NBK557652). Its primary biological function is the regulation of peristaltic movement and the coordination of local reflexes in response to luminal stimuli. The colonic wall provides the physical barrier and the contractile machinery necessary for the transport and processing of fecal matter (NCBI, NBK507857). In clinical pharmacology, this 'target' is often cited when a drug's effect is localized to the gut, though the actual molecular interaction usually occurs at specific receptors like 5-HT4 or mu-opioid receptors found on the neurons or myocytes within these layers. Pathological changes in these components are central to diseases such as Hirschsprung disease, where the plexus is absent, or irritable bowel syndrome, characterized by hypersensitivity and dysmotility. Therapeutic agents targeting this region often aim to modulate the enteric nervous system to treat constipation, diarrhea, or inflammatory conditions. Because this entry refers to a broad anatomical region rather than a single protein or gene product, it is generally considered a non-specific or system-level target in drug discovery databases.

Other names
Auerbach's plexusEnteric nervous system of the colonMyenteric plexusGastrointestinal wall components
02

Mechanism of action

Drugs typically modulate enteric neurotransmission or smooth muscle activity by binding to specific receptors (e.g., 5-HT4, mu-opioid, or guanylate cyclase-C) located within the layers of the colonic wall or the neurons of the myenteric plexus.

03

Biological functions

Gastrointestinal motilityPeristalsisSignal transductionSecretomotor regulationIntestinal barrier function
04

Disease associations

Irritable bowel syndromeHirschsprung diseaseInflammatory bowel diseaseChronic idiopathic constipationAchalasia
05

Safety considerations

Gastrointestinal perforationIschemic colitisSevere diarrheaElectrolyte imbalanceTachyphylaxis
06

Interacting drugs

Prucalopride

5 more in the full profile.

07

Biomarkers

Colonic transit timeFecal calprotectinAnorectal manometry profiles

Beyond the preview

Go deeper on Colonic wall and myenteric plexus components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic wall and myenteric plexus components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call